The deal – financial terms of which have not been disclosed – will see Adroit work with Recipharm’spharmaceutical development services business.
Carl-Johan Spak, Executive Vice President, development and technology at Recipharm, predicted that the partnership would increase efficiency and help customers get to market faster.
“Adroit Science AB has fast established itself as one of the leading providers of solid state characterisation services in Northern Europe. Indeed, we can offer an even better service to our customers through this collaboration, including complete development from molecule to product.”